Trial Watch

Clinical trials covered by The Clinical Lighthouse, ranked by methodological rigor and ordered by most recent.

190 trials indexed
Favipiravir Safe, Well-Tolerated for Mild-to-Moderate Lassa Fever
PIVOTAL TRIAL · LAST 30 DAYS
Randomized Controlled Trial Nature Medicine

Favipiravir Safe, Well-Tolerated for Mild-to-Moderate Lassa Fever

A phase 2 trial in Nigeria provides pharmacokinetic data and supports favipiravir as an alternative to ribavirin for Lassa fever.

May 17, 2026 Read the trial →
Cesium-131 Collagen Tiles Improve Local Control in Recurrent Meningioma Non-Randomized Controlled Trial
Journal of neurosurgery

Cesium-131 Collagen Tiles Improve Local Control in Recurrent Meningioma

A phase 2 trial shows resection plus brachytherapy achieves 48% local control at five years for aggressive, recurrent meningiomas.

April 29, 2026
Targeted sFlt-1 Apheresis Safely Extends Pregnancy in Very Preterm Preeclampsia Non-Randomized Controlled Trial
Nature Medicine

Targeted sFlt-1 Apheresis Safely Extends Pregnancy in Very Preterm Preeclampsia

A pilot trial shows selective removal of sFlt-1 reduces maternal blood pressure and delays delivery by a median of 10 days.

April 29, 2026
Oral Factor D Inhibitor Fails to Improve Myasthenia Gravis Symptoms Randomized Controlled Trial
JAMA Neurology

Oral Factor D Inhibitor Fails to Improve Myasthenia Gravis Symptoms

A phase 2 trial of vemircopan was terminated after the oral complement inhibitor showed no significant benefit over placebo.

April 29, 2026
Pulsed Field Ablation Reduces Recurrence in Persistent Atrial Fibrillation Randomized Controlled Trial
New England Journal of Medicine

Pulsed Field Ablation Reduces Recurrence in Persistent Atrial Fibrillation

First-line pulsed field ablation showed a 56% success rate at 12 months compared to 30% for antiarrhythmic drugs in a randomized trial.

April 28, 2026
Alternating Venetoclax Triplets Extend Survival in Older AML Patients Non-Randomized Controlled Trial
American Journal of Hematology

Alternating Venetoclax Triplets Extend Survival in Older AML Patients

A phase 2 trial shows a 45% five-year survival rate and high rates of deep molecular remission using an alternating low-intensity regimen.

April 28, 2026
Mailed FIT-DNA Increases Colorectal Cancer Screening Rates in Community Health Centers Randomized Controlled Trial
JAMA Internal Medicine

Mailed FIT-DNA Increases Colorectal Cancer Screening Rates in Community Health Centers

A pragmatic trial shows mailed FIT-DNA outreach achieves higher screening uptake than standard FIT, though follow-up colonoscopy rates remain low.

April 28, 2026
Videolaryngoscopy Increases First-Attempt Success for Double-Lumen Tube Intubation Randomized Controlled Trial
British Journal of Anaesthesia

Videolaryngoscopy Increases First-Attempt Success for Double-Lumen Tube Intubation

A multicenter trial of 916 patients shows digital visualization improves glottic view and reduces esophageal intubation rates.

April 28, 2026
Online Therapist-Assisted Program Reduces Posttraumatic Stress in Injured Children Randomized Controlled Trial
JAMA Pediatrics

Online Therapist-Assisted Program Reduces Posttraumatic Stress in Injured Children

A randomized trial shows a digital cognitive behavioral intervention lowers symptom scores for six months following pediatric hospitalization.

April 28, 2026
Repeat OnabotulinumtoxinA for Masseter Prominence Does Not Alter Mandibular Bone Randomized Controlled Trial
Aesthetic Surgery Journal

Repeat OnabotulinumtoxinA for Masseter Prominence Does Not Alter Mandibular Bone

A 12-month placebo-controlled trial using CT imaging shows no significant bone remodeling after masseter injections for facial contouring.

April 28, 2026
Trabeculectomy Slows Visual Field Loss Better Than Medication in Advanced Glaucoma Randomized Controlled Trial
Ophthalmology

Trabeculectomy Slows Visual Field Loss Better Than Medication in Advanced Glaucoma

A five-year trial shows surgery preserves monocular vision but finds no significant difference in patient-reported quality of life.

April 28, 2026
Symptom-Based Dosing Reduces Discharge Time in Neonatal Opioid Withdrawal Randomized Controlled Trial
JAMA

Symptom-Based Dosing Reduces Discharge Time in Neonatal Opioid Withdrawal

A cluster randomized trial shows symptom-based dosing shortens medical readiness for discharge when paired with the Eat, Sleep, Console model.

April 28, 2026
Proximal Nerve Stimulation Improves Sleep Apnea in CPAP-Intolerant Patients Randomized Controlled Trial
Annals of Internal Medicine

Proximal Nerve Stimulation Improves Sleep Apnea in CPAP-Intolerant Patients

A randomized trial shows proximal hypoglossal nerve stimulation significantly reduces apnea-hypopnea index and daytime sleepiness.

April 27, 2026
Luvadaxistat Fails to Improve Schizophrenia Cognition in Phase 2 Trial Randomized Controlled Trial
Neuropsychopharmacology

Luvadaxistat Fails to Improve Schizophrenia Cognition in Phase 2 Trial

The ERUDITE study found no significant cognitive benefit from adding the D-amino acid oxidase inhibitor to stable antipsychotic therapy.

April 27, 2026
Physical Therapy Improves Function More Than CBT in Chronic Low Back Pain Randomized Controlled Trial
Annals of Internal Medicine

Physical Therapy Improves Function More Than CBT in Chronic Low Back Pain

A sequential randomized trial finds physical therapy superior for initial functional gains, though secondary strategies show no difference.

April 27, 2026
Counterconditioning Stabilizes Neural Safety Signals in PTSD Randomized Controlled Trial
Translational Psychiatry

Counterconditioning Stabilizes Neural Safety Signals in PTSD

Functional MRI shows pairing threat stimuli with positive outcomes reinforces safety patterns in the ventromedial prefrontal cortex.

April 27, 2026
Palliative Telecare Fails to Improve Goal Concordance in Cardiopulmonary Disease Randomized Controlled Trial
Journal of Palliative Medicine

Palliative Telecare Fails to Improve Goal Concordance in Cardiopulmonary Disease

A randomized trial of nurse and social worker-led phone interventions found no change in treatment alignment or patient uncertainty.

April 27, 2026
Specific RehaCom Modules Predict Processing Speed Gains in Progressive Multiple Sclerosis Randomized Controlled Trial
Neurorehabilitation and Neural Repair

Specific RehaCom Modules Predict Processing Speed Gains in Progressive Multiple Sclerosis

Progression in attention-based modules and baseline characteristics like IQ and age determine cognitive outcomes in progressive MS.

April 27, 2026
NIRS-Guided Resuscitation Improves Early Motor Scores in Preterm Infants Randomized Controlled Trial
Neonatology

NIRS-Guided Resuscitation Improves Early Motor Scores in Preterm Infants

A COSGOD III sub-study shows that monitoring cerebral oxygenation in the first 15 minutes of life correlates with better motor repertoire.

April 27, 2026
Balanced Fluids and Saline Show Similar Outcomes in Pediatric Septic Shock Randomized Controlled Trial
New England journal of medicine

Balanced Fluids and Saline Show Similar Outcomes in Pediatric Septic Shock

A large trial of over 8,000 children found no difference in kidney events or mortality between balanced crystalloids and 0.9% saline.

April 27, 2026
Targeted Agents Fail to Extend Survival in Pediatric Brainstem Glioma Randomized Controlled Trial
Nature Medicine

Targeted Agents Fail to Extend Survival in Pediatric Brainstem Glioma

The BIOMEDE trial finds no survival benefit for erlotinib, dasatinib, or everolimus, but identifies TP53 as a key prognostic marker.

April 27, 2026
Pitch Gestures Increase Prefrontal Activation During Mandarin Tone Sandhi Perception Non-Randomized Controlled Trial
Frontiers in Neuroscience

Pitch Gestures Increase Prefrontal Activation During Mandarin Tone Sandhi Perception

Training with physical gestures strengthens functional connectivity in the left dorsolateral prefrontal cortex to improve auditory discrimination.

April 26, 2026
Triple-Pill Therapy Reduces Recurrent Stroke Risk After Intracerebral Hemorrhage Randomized Controlled Trial
New England Journal of Medicine

Triple-Pill Therapy Reduces Recurrent Stroke Risk After Intracerebral Hemorrhage

A low-dose combination of telmisartan, amlodipine, and indapamide lowered systolic blood pressure and major cardiovascular events.

April 26, 2026
Phenylephrine Drops Match Eyelid Taping for Ptosis Insurance Qualification Non-Randomized Controlled Trial
Ophthalmic Plastic and Reconstructive Surgery

Phenylephrine Drops Match Eyelid Taping for Ptosis Insurance Qualification

A comparative study shows phenylephrine 2.5% achieves similar visual field gains as taping with significantly higher patient satisfaction.

April 26, 2026
Brolucizumab Preserves Vision Better Than Laser in Diabetic Retinopathy Randomized Controlled Trial
JAMA Ophthalmology

Brolucizumab Preserves Vision Better Than Laser in Diabetic Retinopathy

The Phase 3 CONDOR trial shows brolucizumab 6 mg maintains visual acuity and regresses disease more effectively than panretinal laser.

April 26, 2026
Left Bundle Branch Pacing Reduces Cardiomyopathy Risk in High-Burden Patients Randomized Controlled Trial
Journal of the American College of Cardiology

Left Bundle Branch Pacing Reduces Cardiomyopathy Risk in High-Burden Patients

A randomized trial shows left bundle branch pacing lowers composite clinical events and improves ventricular function over 36 months.

April 26, 2026
Dupilumab Resolves Airway Mucus Plugs and Reduces Radiodensity in Asthma Non-Randomized Controlled Trial
CHEST Journal

Dupilumab Resolves Airway Mucus Plugs and Reduces Radiodensity in Asthma

A longitudinal CT analysis shows dupilumab clears 91% of existing mucus plugs and alters the physical composition of remaining obstructions.

April 26, 2026
Donor-Derived Anti-CD33 CAR T-Cells Show Safety in Relapsed AML Post-Transplant Non-Randomized Controlled Trial
Blood

Donor-Derived Anti-CD33 CAR T-Cells Show Safety in Relapsed AML Post-Transplant

A phase 1/2 trial of VCAR33 demonstrates manageable toxicity and preliminary activity in patients with relapsed or MRD-positive disease.

April 25, 2026
Baricitinib Noninferior to Etanercept for Reducing Ultrasound-Assessed Synovitis Randomized Controlled Trial
Annals of the Rheumatic Diseases

Baricitinib Noninferior to Etanercept for Reducing Ultrasound-Assessed Synovitis

A phase IV trial shows baricitinib, with or without methotrexate, matches etanercept in objective measures of joint inflammation.

April 25, 2026
Remote Ischaemic Preconditioning Fails to Prevent Postoperative Myocardial Injury Randomized Controlled Trial
British Journal of Anaesthesia

Remote Ischaemic Preconditioning Fails to Prevent Postoperative Myocardial Injury

A randomized trial of two-session preconditioning in abdominal surgery shows no reduction in injury and a paradoxical troponin increase.

April 25, 2026
Vuzix Head-Mounted Device Scores Highest in Prehospital Stroke Triage Simulation Non-Randomized Controlled Trial
Scandinavian Journal of Trauma Resuscitation and Emergency Medicine

Vuzix Head-Mounted Device Scores Highest in Prehospital Stroke Triage Simulation

A comparative study finds neurologists prefer head-mounted video quality while paramedics favor smartphone usability for remote triage.

April 25, 2026